AI assistant
Medica — M&A Activity 2022
Sep 13, 2022
4116_rns_2022-09-13_0dc64dbd-dd71-4d9c-bcc2-40902340b7a5.pdf
M&A Activity
Open in viewerOpens in your device viewer
MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY
Tel. 0535 51159 Fax 0535 52605 e-mail: [email protected] home page: www.medica.it
MEDICA ACQUIRES THE RESIDUAL 40% OF TECNOIDEAL AMERICA INC, COMMERCIAL COMPANY ALREADY CONTROLLED BY MEDICA
Medolla (MO), 13 September 2022 – Medica S.p.A., an integrated Italian biomedical and MedTech group with a strong international footprint, announces the acquisition, through its subsidiary Tecnoideal Srl, by Ludovico Giavotto of 40% of the share capital of Tecnoideal America Inc, commercial company of Medica Group since its foundation, dedicated to the development of the Automation business in the American market.
The current acquisition thus brings to 100% the stake of Tecnoideal Srl in the share capital of Tecnoideal America Inc..
The consideration for the transaction is Euro 0.3 million (approximately equal to the shareholders' equity of third parties), is not subject to adjustments and is fully financed by available liquidity.
The acquisition of the remaining 40% of Tecnoideal America Inc. contributes to the vertical integration of the Medica Group, with a view to complete monitoring of the value chain. As proof of our confidence in his management skills, Ludovico Giavotto has been confirmed in the role of CEO of Tecnoideal America Inc.
***
Medica Profile
Medica Group is operating since 1985 in the biomedical district of Mirandola (Italy). Development of innovative products for blood purification has always been company's core business. Thanks to the activity of two extremely dynamic R&D groups (medical equipment, membranes and disposable), the Group competes successfully in several markets, namely:
- Medical (dialysis, CRRT, ECCO2, Apheresis, DFPP, CHF, HIPEC, pre-transplant organ perfusion, bioregenerative medicine, gastroenterology, urodynamics, oxygen humidification).
- Microbiological purification of water
- Industrial automation for the biomedical sector.
R&D focus has been integrated over the years with a highly automated production systems in five different facilities, four in Italy and one in Tunisia, and two commercial entities (in US and in China).
The key success factors of the Group are:
- extrusion of hollow fiber membranes for hemofiltration, plasmapheresis, cascade filtration, oxygen humidification, ultrafiltration and microfiltration of water
- vertical integration, proved by the ability to manage not only the design and development of medical disposables and equipment, and the development of the automation technologies required for their production as well.
- International recognition with significant share of export, with sales in over 60 countries.
MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY
Tel. 0535 51159 Fax 0535 52605 e-mail: [email protected] home page: www.medica.it
International: Tel. +39 0535 51159 Fax +39 0535 52605
The Medica group closed its consolidated financial statements for 2021 with revenues of 43.8 million euros (44.1 million euros in 2020), EBITDA of 9.9 million euros (9.5 million euros in 2020), EBIT of € 5.8 million (€ 5.6 million in 2020) and net profit of € 5.0 million (€ 3.8 million in 2020).
For information: Investor Relations Medica Giovanni Plasmati (+39) 0535 51159 [email protected]
Euronext Growth Advisor CFO SIM S.p.A. (+39) 02 303431 [email protected]
UNI CEI EN ISO 9001:2015 UNI CEI EN ISO 13485:2016
Capitale sociale € 4.223.250,00 i.v. – Registro Ditte/REA n° 229672 – Registro Imprese di Modena n° 01604300366 Iscrizione Registro Nazionale Produttori A.E.E. n. IT08020000003645 Partita IVA e Codice Fiscale 01604300366 – Identification Number IT 01604300366